LAS VEGAS—Modifiable cardiovascular (CV) risk factors remain undertreated in a very high-risk population of patients with chronic kidney disease (CKD), new findings presented at the National Kidney Foundation’s Spring Clinical Meetings suggest.
LAS VEGAS—Sodium thiosulfate may hold promise as a treatment for calciphylaxis in patients with end-stage renal disease (ESRD), researchers reported here at the National Kidney Foundation’s Spring Clinical Meetings.
LAS VEGAS—Obesity, current smoking, and diet are modifiable risk factors for developing chronic kidney disease (CKD), according to study findings presented at the National Kidney Foundation’s Spring Clinical Meetings.
LAS VEGAS—Bisphosphonate treatment in women with non-dialysis dependent chronic kidney disease (NDD-CKD) is associated with a decreased risk of death, but not of cardiovascular events, according to data presented at the National Kidney Foundation’s Spring Clinical Meetings.
LAS VEGAS—Treatment of 25-hydroxyvitamin D (25(OH)D) deficiency with ergocalciferol in patients with moderate chronic kidney disease (CKD) is associated with a significant reduction in the risk of cardiovascular (CV) events, new data presented at the National Kidney Foundation’s Spring Clinical Meetings suggest.
LAS VEGAS—Women with an estimated glomerular filtration rate (eGFR) of 60 mL/min/1.73 m2 or higher are at higher risk than men for experiencing radiocontrast-induced nephropathy (RCIN) following coronary angiography, investigators reported at the National Kidney Foundation’s Spring Clinical Meetings.
LAS VEGAS—Pulmonary hypertension is a strong predictor of the need for renal replacement therapy (RRT) after lung transplantation, according to new findings presented at the National Kidney Foundation’s Spring Clinical Meetings.
LAS VEGAS—Even modest rises in serum potassium at critical care initiation is a significant predictor of all-cause mortality, according to findings presented here at the National Kidney Foundation’s Spring Clinical Meetings.
LAS VEGAS—Sustained low-efficiency daily dialysis (SLEDD) for intensive care unit (ICU) patients does not offer a survival advantage over intermittent hemodialysis (IHD), according to data reported at the National Kidney Foundation’s Spring Clinical Meetings.
LAS VEGAS—Race does not appear to affect the likelihood of progression to end-stage renal disease and overall mortality among obese individuals with chronic kidney disease (CKD), according to study findings presented at the National Kidney Foundation’s Spring Clinical Meetings.
Please login or register first to view this content.
